http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-831897-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97a285d8ecd0184a7e5d89a1e4e07997
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 1957-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b373bae6e0db5502f9c0fcac4326699a
publicationDate 1960-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-831897-A
titleOfInvention Antacid preparation and process for making same
abstract An antacid preparation comprises a non-toxic antacid substance which is an oxide, hydroxide, carbonate or hydroxy salt of magnesium together with a non-toxic water-soluble synthetic polymer which is a polymer of acrylic acid cross-linked with a polyhydroxy compound having at least 3 hydroxy groups, such as a polyhydroxy alcohol, wherein the hydrogen atoms of at least three hydroxyl groups are replaced with unsaturated aliphatic radicals, preferably having 2-4 carbon atoms, or cross-linked with an unsaturated ether or unsaturated saccharide ether or unsaturated ester having at least three double bonds available for cross-linking such as the tri-acrylic acid ester of glycerol and acrylic acid esters of glycerol having from 3-8 acid residues. The polyhydroxy compounds specified are glucose, fructose, mannose, galactose, sucrose, lactose, maltose, glycerol, erythritol, dulcitol, mannitol, sorbitol, pentaerythritol. The preferred cross-linkers are polyallyl sucrose and polyallyl pentaerythritol, preferably present from 0.75 to 1.5% by weight with respect to the polymer. The cross-linked polymer may be subjected to the action of steam to form a porous cake, the cake being dried and milled to a predetermined size. The antacid and polymer are preferably present in the ratio by weight of 1 part of polymer to 1-6 parts of antacid. For tabletting binders such as gelatin, gum acacia, tragacanth, pectin and diluents such as starch, talc and terra alba may be used.ALSO:An antacid preparation comprises a non-toxic antacid substance p which is an oxide, hydroxide, carbonate or hydroxy salt of magnesium together with a non-toxic water-soluble synthetic polymer which in aqueous solution forms a gel at a pH above 4.5 but which remains fluid at a lower pH. The polymer used should preferably buffer the antacid to lower the pH and increase in viscosity after passing into the duodenum to provide a bulking action. Specified is a polymer of acrylic acid cross-linked with a polyhydroxy compound having at least 3 hydroxy groups, such as a polyhydroxy alcohol, wherein the hydrogen atoms of at least three hydroxyl groups are replaced with unsaturated aliphatic radicals preferably having 2-4 carbon atoms, or cross-linked with an unsaturated ether or unsaturated saccharide ether or unsaturated ester having at least three double bonds available for cross-linking, such as the tri-acrylic acid ester of glycerol and acrylic acid esters of glycerol having from 3-8 acid residues. The polyhydroxy compounds specified are glucose, fructose, mannose, galactose, sucrose, lactose, maltose, glycerol, erythritol, dulcitol, mannitol, sorbitol pentaerythritol. The preferred cross-linkers are polyallyl sucrose and polyallyl pentaerythritol, preferably present from 0.75% to 1.5% by weight with respect to the polymer. The cross-linked polymer may be subjected to the action of steam to form a porous cake, the cake being dried and milled to a predetermined size. The antacid and polymer are preferably present in the ratio by weight of 1 part of polymer to 1-6 parts of antacid. For tabletting binders such as gelatin, gum acacia, tragacanth, pectin and diluents such as starch, talc and terra alba may be used.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018204317-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110709068-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110709068-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110780063-A
priorityDate 1957-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID169019
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407699550
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8285
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559376
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451577747
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222285
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037556
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23501970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474364
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5988
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559552
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530273
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322818
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID138043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419593172
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93091914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID752
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412833275
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID339493
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5984
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82170
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID138043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581501
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18950
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID339493
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559568
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496967
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531362
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11850

Total number of triples: 76.